Sonneveld, P., Moreau, P., Einsele, H., Quach, H., Ho, P., Beksac, M., Hulin, C., Antonioli, E., Leleu, X., Mangiacavalli, S., Perrot, A., Cavo, M., Belotti, A., Broijl, A., Pei, H., Sitthi-Amorn, A., Carson, R., Rodríguez-Otero, P., Dimopoulos, M. and Boccadoro, M. (2026) “P12 | SUBCUTANEOUS DARATUMUMAB (DARA) + BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE WITH DARA + LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVE”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14037.